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A B S T R A C T
This study investigated whether Raman and Near Infrared (NIR) spectroscopy could predict
tablet properties. Granules were produced on a continuous line by varying granulation pa-
rameters. Tableting process parameters were adjusted to obtain uniform tablet weight and
thickness. Spectra were collected offline and tablet properties determined with traditional
analyzing methods. Partial Least Squares (PLS) regression was used to correlate spectral in-
formation to tablet properties, but predictive models couldn’t be established. Principal
component analysis (PCA) was effectively used to distinguish theophylline concentrations
and hydration levels and multiple linear regression (MLR) analysis allowed insight on how
granulation parameters affect granule and tablet properties.
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1. Introduction
Most pharmaceutical manufacturing nowadays is still per-
formed using batch manufacturing processes. In contrast to
other industries (e.g. petrochemical, chemical and food indus-
tries) that transferred to continuous manufacturing decades
ago, the pharmaceutical industry has been reluctant to move
from batch processing toward continuous processing. Rigor-
ous regulatory constraints, among others, can be identified as
one of the reasons for this [1–6]. However, since the publica-
tion of the United States Food and Drug Administration’s (FDA)
Pharmaceutical current Good Manufacturing Principles (cGMPs)
for the 21st century initiative, there has been a shift toward
regulatory authorities encouraging the pharmaceutical indus-
try to implement new technology.The International Conference
on Harmonization (ICH) guidelines Q8 [7], Q9 [8] and Q10 [9]
together with the Process Analytical Technology (PAT) – Guid-
ance for Industry [10] and the Process Validation – Guidance
for Industry [11] introduced the concepts of Quality by Design
(QbD) and the use of science and risk-based approaches to
assure product quality [1].
The production of tablets on a high speed rotary tablet press
is by definition a classic example of a continuous process. As
long as the machine is fed with material, tablets will be pro-
duced and ejected at the ejection station.The production speed
of an industrial tablet press gives an extremely large output
(i.e. several hundreds of thousands of tablets per hour). If ana-
lyzing methods guaranteeing the quality of the end product
are optimized, this results in a shorter “time-to-market” and
a cost and floor space reduction, as there is less need for storage.
In theory, however, tablet quality is still mainly assessed offline
by performing traditional methods of analysis on tablets col-
lected at the end of production. These methods are often
destructive and involve sample pretreatment. As a conse-
quence, the latter becomes the rate-limiting step and annuls
the advantages of the fast continuous production process. Con-
sequently, to allow real-time release, other techniques are
necessary. Evidently, the use of PAT-tools is a vital element in
this process.
In contrast to the classical analyzing methods, spectro-
scopic techniques offer a rapid, simple, non-invasive and non-
destructive alternative requiring little or even no sample
preparation. Near Infrared (NIR) and Raman spectra carry sig-
nificant chemical and physical features of the samples but since
these often overlap it is difficult to get information directly from
the spectra. Therefore, multivariate data analysis tools such
as Principal Component Analysis (PCA) are essential to extract
and summarize this information [12]. NIR reflectance and also
transmittance measurements have been reported as reliable
methods for the identification and quantification of active phar-
maceutical ingredients (APIs) in tablets [13]. NIR spectroscopy
has also already been used for the prediction of tablet hard-
ness [14–18], porosity [19] and disintegration time [20] of tablets
prepared at different compression forces. Some publications
also reported about the application of Raman spectroscopy to
determine tablet properties [12,19,21]. Wang et al. [21] and
Johansson et al. [12] studied the use of Raman spectroscopy
in the prediction of tablet hardness. Raman spectroscopy was
also used by Shah et al. [19] to predict the porosity of ex-
tended release matrix tablets. It is crucial to emphasize that
all of these studies were performed on tablets prepared using
different compression forces, hence resulting in tablets with
a different thickness or a different weight, depending on the
followed approach (i.e. maintaining the weight yields tablets
with lower thickness at higher compression force, whereas
maintaining the thickness requires a higher weight when the
compression force is increased). Moreover, the ranges used in
these studies are rather broad; e.g., Johansson et al. [12] varied
the compression force from 5 to 20 kN with increments of 5 kN.
Other authors used ranges with the highest force being three-
fold [14], sixfold [15–20] or tenfold [13] higher compared to the
lowest applied compression force. Such a wide span in com-
pression force induces significant differences in the extent of
bonding, which forms the basis of spectroscopic models to
predict tablet hardness, porosity and disintegration time.
However, in an industrial manufacturing process (which was
mimicked in our study) the main objective is to maintain the
preset tablet weight, thickness and diameter. Since the quality
constraints are stringent and the rejection limits are often
narrow, the properties of tablets, which do not conform to the
preset specifications (i.e. within-spec tablets), will generally not
differ to the extent reported in other papers. Furthermore, as
differences in weight, thickness and diameter are also known
to affect signals detected via Raman and NIR spectroscopy, it
was the objective of this study to adjust the tableting process
parameters to obtain for all batches tablets of uniform weight,
thickness and diameter. Hence, any differences observed in
tablet characteristics could only be due to the differences in
granule characteristics.
The primary objective of the present study was to deter-
mine the applicability of NIR and Raman spectroscopy in the
prediction of the physical properties of tablets, using the Partial
Least Squares (PLS) approach. It was further investigated if
these PAT-tools could also be used with the same capability
to determine the concentration and hydrate level of the API
(theophylline). Moreover, the influence of different granula-
tion parameters on granule quality attributes, tablet quality
attributes and associated tableting process parameters was
studied.
2. Materials and methods
2.1. Materials
Theophylline anhydrate was selected as model API and pur-
chased from Farma-QuÍmica Sur (Malaga, Spain). α-lactose
monohydrate 200 M (Caldic, Hemiksem, Belgium) was used as
filler for granulation and polyvinylpyrrolidone (PVP) (Kollidon®30,
BASF, Ludwigshafen, Germany) in a concentration of 2.5% (w/w
to the dry powder) as binder. Distilled water was used as the
granulation liquid.
2.2. Preparation of powder mixtures
Before granulation, three premixes, with different theophyl-
line concentrations (Table 1), were prepared by low shear mixing
(20 min, 25 rpm) in a 20 l stainless steel drum with a filling
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Table 1 – Overview of factor settings and characterization of granules and tablets from the experimental design.
Run Batch
code
Factors Responses of granules Responses of tablets Tableting parameters
Formulation SC BT LFR Fines Oversizedd Friab ρbulk ρtapped CI TS Friab Disint ε VCW FD MCF VC MCF
5 1111 19.50 / 78.00 / 2.50 1 × 4 25 36.2 34.1 9.0 19.7 0.403 0.464 13.1 1.5 0.2 199 26.1 1.9 10.00 6.63 14.5
33 1112 19.50 / 78.00 / 2.50 1 × 4 25 41.2 21.2 17.4 15.4 0.437 0.492 11.2 0.9 4.7* 112 25.4 1.7 9.80 5.61 19.4
3 1113 19.50 / 78.00 / 2.50 1 × 4 25 46.3 10.5 29.0 10.5 0.415 0.464 10.6 0.9 3.7* 188 29.0 1.6 9.35 5.41 13.5
26 1121 19.50 / 78.00 / 2.50 1 × 4 35 36.2 32.1 9.4 16.7 0.432 0.491 12.1 1.2 3.0* 144 28.2 1.6 9.05 5.50 19.5
25 1122 19.50 / 78.00 / 2.50 1 × 4 35 41.2 20.1 16.5 15.6 0.433 0.497 12.9 0.8 8.6* 108 30.4 1.7 9.05 5.68 17.4
4 1123 19.50 / 78.00 / 2.50 1 × 4 35 46.3 14.9 23.3 11.1 0.399 0.456 12.6 0.8 10.9* 195 31.0 2.2 9.30 5.06 12.4
34 1211 19.50 / 78.00 / 2.50 2 × 6 25 36.2 23.4 11.8 14.5 0.448 0.501 10.5 1.2 3.1* 220 22.3 1.9 9.20 5.76 17.1
20 1212 19.50 / 78.00 / 2.50 2 × 6 25 41.2 16.1 19.4 10.9 0.438 0.494 11.4 1.3 0.2 272 28.8 1.8 9.28 5.27 18.9
7 1213 19.50 / 78.00 / 2.50 2 × 6 25 46.3 8.9 37.4 6.5 0.446 0.519 14.1 0.8 8.3* 178 30.0 1.7 9.05 6.11 12.2
8 1221 19.50 / 78.00 / 2.50 2 × 6 35 36.2 20.0 16.2 12.3 0.452 0.509 11.2 0.9 2.9* 218 29.4 1.8 8.90 6.00 22.4
6 1222 19.50 / 78.00 / 2.50 2 × 6 35 41.2 9.6 32.4 10.3 0.442 0.495 10.6 0.7 4.9* 175 31.5 1.7 9.00 5.06 18.2
1 1223 19.50 / 78.00 / 2.50 2 × 6 35 46.3 4.9 43.0 4.3 0.464 0.516 10.0 1.1 0.5 526 21.4 1.5 8.50 6.03 22.3
29 2111 29.25 / 68.25 / 2.50 1 × 4 25 36.2 36.5 7.8 19.7 0.451 0.496 9.0 1.9 0.1 436 24.8 2.0 9.10 5.22 22.2
19 2112 29.25 / 68.25 / 2.50 1 × 4 25 41.2 29.7 11.5 24.7 0.409 0.441 7.3 2.1 0.1 379 27.2 2.0 9.50 5.63 27.9
17 2113 29.25 / 68.25 / 2.50 1 × 4 25 46.3 16.6 23.9 15.3 0.439 0.489 10.2 1.9 0.4 355 27.0 2.1 9.50 5.70 23.0
35 2121 29.25 / 68.25 / 2.50 1 × 4 35 36.2 35.8 7.8 18.8 0.455 0.517 11.9 2.0 0.2 346 20.7 2.1 9.10 5.60 19.2
22 2122 29.25 / 68.25 / 2.50 1 × 4 35 41.2 23.9 15.5 17.3 0.450 0.513 12.2 2.1 0.1 423 27.2 1.9 8.90 5.47 22.3
14 2122R1· 29.25 / 68.25 / 2.50 1 × 4 35 41.2 22.9 15.9 17.5 0.450 0.504 10.7 2.1 0.1 570 26.5 1.8 9.90 5.95 21.0
30 2123 29.25 / 68.25 / 2.50 1 × 4 35 46.3 20.1 14.9 10.8 0.401 0.456 12.0 1.8 1.1* 413 22.7 1.9 9.35 5.63 20.3
12 2211 29.25 / 68.25 / 2.50 2 × 6 25 36.2 33.4 7.6 14.8 0.463 0.517 10.5 2.1 0.3 519 26.8 1.9 8.72 5.56 22.5
28 2212 29.25 / 68.25 / 2.50 2 × 6 25 41.2 26.0 9.0 12.2 0.467 0.517 9.7 1.7 1.4* 559 22.6 2.0 8.75 5.23 23.0
23 2213 29.25 / 68.25 / 2.50 2 × 6 25 46.3 18.2 15.0 9.3 0.487 0.549 11.3 1.4 2.2* 382 27.6 1.7 8.63 5.57 19.1
2 2221 29.25 / 68.25 / 2.50 2 × 6 35 36.2 26.2 10.2 18.5 0.438 0.483 9.2 2.2 0.4 379 23.3 2.0 9.10 5.73 22.4
13 2222 29.25 / 68.25 / 2.50 2 × 6 35 41.2 18.2 17.9 9.2 0.469 0.529 11.3 1.9 0.5 589 25.9 1.9 9.00 5.65 20.4
10 2223 29.25 / 68.25 / 2.50 2 × 6 35 46.3 14.3 17.9 7.5 0.464 0.533 12.9 1.4 2.4* 388 30.1 2.2 9.60 4.98 20.2
18 3111 39.00 / 58.50 / 2.50 1 × 4 25 36.2 40.0 6.2 25.9 0.369 0.432 14.6 1.7 0.3 963 27.6 1.9 10.05 5.76 13.5
37 3112 39.00 / 58.50 / 2.50 1 × 4 25 41.2 27.3 12.9 25.1 0.417 0.479 12.9 1.6 0.1 927 21.3 2.2 9.85 5.45 18.8
36 3113 39.00 / 58.50 / 2.50 1 × 4 25 46.3 26.2 11.0 18.1 0.406 0.457 11.2 2.0 0.1 960 21.3 2.0 9.75 5.42 23.6
16 3121 39.00 / 58.50 / 2.50 1 × 4 35 36.2 36.7 7.5 22.8 0.407 0.466 12.7 2.2 0.1 653 28.0 1.9 9.75 5.57 17.2
27 3122 39.00 / 58.50 / 2.50 1 × 4 35 41.2 26.1 11.8 23.4 0.412 0.463 11.0 2.4 0.1 594 26.0 2.1 9.42 5.55 29.0
9 3123 39.00 / 58.50 / 2.50 1 × 4 35 46.3 22.8 14.3 16.9 0.417 0.456 8.6 2.0 0.2 768 28.5 2.3 9.45 5.75 19.9
31 3211 39.00 / 58.50 / 2.50 2 × 6 25 36.2 43.3 4.4 16.2 0.470 0.523 10.2 2.3 0.1 972 23.8 2.4 8.75 5.79 16.8
24 3212 39.00 / 58.50 / 2.50 2 × 6 25 41.2 28.2 8.1 16.3 0.473 0.528 10.4 2.4 0.1 571 27.1 1.9 8.70 5.60 20.5
32 3213 39.00 / 58.50 / 2.50 2 × 6 25 46.3 18.2 13.4 9.1 0.474 0.539 12.1 2.3 0.1 1129 22.9 2.1 9.00 5.42 23.3
21 3221 39.00 / 58.50 / 2.50 2 × 6 35 36.2 29.1 7.6 16.0 0.440 0.496 11.4 2.6 0.2 935 27.6 2.2 9.30 5.23 23.9
11 3222 39.00 / 58.50 / 2.50 2 × 6 35 41.2 21.3 13.9 14.8 0.435 0.487 10.7 1.8 0.2 1340 27.2 2.0 9.46 5.60 24.8
15 3223 39.00 / 58.50 / 2.50 2 × 6 35 46.3 15.8 14.2 12.1 0.451 0.489 7.8 1.6 0.1 1576 27.6 1.7 9.40 6.38 15.8
Formulation: API/lactose/PVP (%)(w/w); SC, number of kneading elements; BT, barrel temperature (°C); LFR, liquid feed rate (g/min); Fines, <300 μm (%); Oversized, >2000 μm (%); Fria, friability (%);
ρbulk, bulk density (g/ml); ρtapped, tapped density (g/ml); CI, compressibility index (%); TS, tensile strength (MPa); Disint, disintegration time (s); ε, porosity (%); VC W, variation coefficient weight (%);
FD, fill depth (mm); MCF, main compression force (kN); VC MCF, variation coefficient MCF (%).
· at “Batch code” refers to the repetition of the center point.
* at “Fria” depicts the tablet batches that failed the friability test. The values of the responses/parameters are the average of all tablets in each batch.
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degree of 60%, using a tumbling mixer (Inversina, Bioengineer-
ing, Wald, Switzerland).
2.3. Granulation
Granulation experiments were performed using a high-shear
co-rotating twin screw granulator, being the granulation unit
of the ConsiGma™-25 continuous powder-to-tablet line (GEA
Pharma Systems - Collette™, Wommelgem, Belgium), which
has already been thoroughly described by other authors
[1,4,6,22,23]. Depending on the experiment (Table 1), the con-
centration of theophylline (API conc), liquid feed rate (LFR), barrel
temperature (BT) and amount of kneading elements (screw con-
figuration (SC)) were changed [4]. The powder premix was
gravimetrically dosed at a constant feed rate of 25 kg/h onto
the screws (950 rpm) and the granulation liquid (distilled water)
was pumped into the screw chamber in front of the first knead-
ing element by two peristaltic pumps. After a calibration time
of 60 sec, for each run 600 g of granules was collected at the
outlet of the granulator. The wet granules were spread on a
tray and oven-dried at 40 °C during 24 h. After drying, a part
of the granules was used for granule characterization.The rest
of the batch was used as such to produce tablets.
2.4. Tableting
Tablets were prepared by single compression (no
precompression) using a high speed rotary tablet press
(MODUL™ P, GEA Pharma Systems – Courtoy™, Halle, Belgium)
equipped with ten punches (Ø = 9 mm, flat faced bevel edge,
no embossing). In order not to impair Raman and NIR mea-
surements, it was important that all tablets had the same
thickness (4 mm), diameter (9 mm) and weight (300 mg). Fill
depth (FD) was adjusted before each experiment to obtain the
desired weight. Paddle speeds (10–20 rpm), tableting speed
(20 rpm) and distance between the punches under compres-
sion (3.25 mm) were kept constant. Hence, observed differences
in physical properties of the tablets are only caused by the dif-
ferences in granule characteristics and not by the tableting
process parameters. Moreover, several tableting parameters (fill
depth, compression force and variability of the compression
force) could also be defined as a response of the granule char-
acteristics. Although the fill depth is set at the beginning of
each experimental run and kept constant, its absolute value
is dependent on the flow properties of the granules. The com-
pression force and its variability are parameters dependent on
the compressibility and packing properties of the granules.Mean
weight was kept constant for all experiments, but small varia-
tions are inherent to the dynamics of the process. Consequently,
as weight variability could only be influenced by the granule
characteristics (flow properties) since tableting speed and paddle
speeds stayed the same throughout all experiments [24], this
parameter was also taken into account as a response.The forced
feeder was filled with 400 g of granules. The machine was run
for 60 seconds and then tablets were sampled during 60
seconds. Room temperature (21 ± 2 °C) and relative humidity
(30 ± 2%) were controlled.Tablets were collected in bags, placed
in an environmental controlled room (T = 21 ± 2 °C; RH = 30 ± 2%)
and allowed to relax for 24 h. Before analysis, 72 tablets out
of each bag were placed in tablet trays, with a separate slot
for each tablet, assigning them an individual identity.This was
preserved through all further analysis (Raman spectroscopy,
NIR spectroscopy and reference analysis) to correlate results
between different analytical techniques.
2.5. Design of experiments
The experimental ranges for the Design of Experiments (DoE)
factors (granulation parameters: API conc, LFR, BT and SC) were
chosen based on a former study [22].The concentration of the-
ophylline was set at three levels (19.5, 29.25 or 39% (w/w to the
dry powder mix)) and achieved by preblending the API, 2.5%
PVP and the remaining amount of lactose by low shear mixing.
Also the liquid feed rate was varied at three levels (36.2, 41.2
and 46.3 g/min) corresponding to a water concentration of 8,
9 and 10% respectively, calculated on wet mass.The full length
of the barrel was preheated, either to 25 or 35 °C. As fourth
process parameter, the amount of kneading elements was
varied between 4 and 12. When 12 kneading elements were
used, two kneading zones each consisting of 6 kneading ele-
ments were assembled, separated by a conveying element and
an extra conveying element after the second kneading block
[25]. For both screw configurations (1 × 4, 2 × 6), the angle of the
kneading elements was kept constant at 60°.
As the amount of process parameters was relatively low
(four) as well as the levels at which they were explored (two
or three), a full factorial design was justified. Furthermore, since
each level of each process parameter could be combined with
each level of another process parameter, the experimental
region could be identified as regular, which is a requisite for
a (full) factorial design. Since a full-factorial design gives the
maximum amount of information compared to other designs
as this arrangement enables the effect of one factor to be as-
sessed independently of all the other factors [26], this approach
was followed.The combination of 2 factors at three levels and
2 factors at two levels resulted in (32 × 22) 36 experiments. One
repetition of the center point was added, which leads to a total
of 37 experiments. An overview of the DoE is given in Table 1.
2.6. Granule characterization
Particle size analysis was done by sieve analysis, using a sieve
shaker (Retsch VE 1000, Haan, Germany). 65 g of granules was
placed on the upper sieve of the set (150, 300, 500, 710, 1000,
1400 and 2000 μm) and shaken at an amplitude of 2 mm for
5 min, after which the amount retained on each sieve was de-
termined. Fines and oversized agglomerates were defined as
the fractions <300 and >2000 μm, respectively.
Granule friability was determined using a friabilator (Pharma
Test PTF E, Hainburg, Germany) at a speed of 25 rpm for 10 min,
by placing 10 g (Winitial) of granules together with 200 glass beads
(mean diameter 4 mm) into the drum and subjecting them to
falling shocks. Before determination, the granule frac-
tion <150 μm was removed to assure the same starting
conditions. After ending a test, the glass beads were removed
and the weight of the granules retained on the 150 μm sieve
(Wfinal) was determined. Each sample was measured in tripli-
cate. The friability was calculated using Equation (1).
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Friability %( ) = −⎛⎝⎜ ⎞⎠⎟ ×
W W
W
initial final
initial
100 (1)
Bulk and tapped density of the granules (30 g) were deter-
mined in a 100ml graduated cylinder.The granules were poured
from a height of 40 cm through a stainless steel funnel with
a 10 mm orifice into the graduated cylinder, mounted on a
tapping machine (J. Engelsmann, Ludwigshafen am Rhein,
Germany). The granules were allowed to settle loosely under
the influence of gravity and the initial volume (V0) was re-
corded. The sample was tapped for 1250 times and the final
volume (V1250) was determined. Each sample was measured in
duplicate. Bulk (ρbulk) and tapped (ρtapped) densities were calcu-
lated as 30 g/V0 and 30 g/V1250, respectively. These values were
used to calculate the compressibility index (CI) (Equation (2))
[27].
CI %( ) = −⎛⎝⎜
⎞
⎠⎟ ×
ρ ρ
ρ
tapped bulk
tapped
100 (2)
2.7. Tablet evaluation by reference analyzing techniques
Hardness, thickness and diameter of tablets (n = 20) were de-
termined with a semi-automated hardness tester (Sotax HT
10, Basel, Switzerland).The tablet tensile strength (TS) was cal-
culated according to Fell and Newton (Equation (3)) [28].
TS MPa( ) = ×
× ×
2 F
d tπ
(3)
where F, d and t stand for the diametral crushing force (N), the
tablet diameter (mm) and the tablet thickness (mm),
respectively.
Tablet friability was determined using a friabilator de-
scribed in European Pharmacopeia (Pharma Test PTF E,
Hainburg, Germany), at a speed of 25 rpm for 4 min. Tablets
(n = 22) were dedusted and weighed before (Winitial) and after
ending (Wfinal) a test. The percentage weight loss expresses the
tablet friability and was calculated using Equation (1). In those
cases where cracked, cleaved or broken tablets were detected
after friability testing, it was reported in the results that these
batches failed the test.
To calculate the porosity (ε) of the tablets, the apparent
density (ρapp) of the tablets was determined. Five dimensions
of 10 tablets with known weight were measured with a pro-
jection microscope (Reickert, 96/0226, Vienna, Austria).
Subsequently, the volume of the tablet was calculated accord-
ing to Equation (4).
V mm3 1
2
1
2
2
2
3
2
2
2
1
3 2 2
( ) = × ⎛⎝ ⎞⎠ ×⎛⎝⎜
⎞
⎠⎟
⎡
⎣⎢
+ × × × ⎛⎝ ⎞⎠ + ⎛⎝ ⎞⎠ +
π
π
D
H
H
D D D2 3
2 2
×
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦⎥
D
(4)
where H1 and D1 are the height and diameter of the central
cylinder respectively, and H2, D2 and D3 are the height, diam-
eter of lower base and diameter of upper base of the conical
frustum (horizontally sliced cone) respectively.Weight divided
by the volume of the tablet resulted in the apparent density
(ρapp). Based on the true density of the granules (ρtrue) deter-
mined by helium pycnometry (Accupyc 1330 pycnometer,
Micrometrics Instruments, Norcross, GA, USA), with ten purges
and ten runs per measurement (n = 3), the porosity of the tablets
was calculated according to Equation (5).
ε
ρ
ρ
%( ) = −⎛⎝⎜
⎞
⎠⎟ ×1 100
app
true
(5)
Disintegration time (sec) was determined (n = 6) using the
apparatus described in European Pharmacopeia (PTZ-E Pharma
Test, Hainburg, Germany). Tests were performed in distilled
water at 37 ± 0.5 °C using disks.
2.8. Prediction of tablet properties using
spectroscopic techniques
All 72 tablets from each DoE batch were measured with a NIR-
Flex N500 transmission FT-NIR spectrometer (BUCHI,
Switzerland) using the NIRWare software. This system con-
tains a tablet holder, isolated from external light sources that
can contain up to 10 tablets at a time.The tablet holder mini-
mizes light scattering effects unrelated to the tablet physical
properties, providing a robust measurement method. Spectra
were collected with 128 scans over the range 11,520 cm−1 to
6000 cm−1 with a resolution of 4 cm−1 and an acquisition time
of 38 seconds.
The same tablets were also measured with a RamanRxn2
Analyzer (Kaiser Optical Systems) based on a 785 nm excita-
tion laser with a power of 400mW and a charged coupled device
(CCD). Samples were irradiated from above through a PhAT
probe (backscattering geometry) and from underneath (using
the transmission accessory), collecting the signal for Raman
shifts in the range 150 cm−1 to 1890 cm−1 with a resolution of
0.3 cm−1 and an acquisition time of 15 sec for the backscatter-
ing geometry and 55 sec for the transmission geometry.Tablets
were placed in an automated tablet holder to minimize light
scattering effects unrelated to the tablet physical properties.
The probe was fixed at a 25 cm distance from the holder. To
prevent background noise, measurements were performed in
complete darkness by covering both tablet holder and PhAT
probe with a black cover. No human interference was neces-
sary during the measurements, resulting in a very robust
procedure.
PCA models were built to provide an overview of the col-
lected data. Individual PLS models were developed for the
prediction of the tablets’ physical properties (friability, tensile
strength, porosity and disintegration time) and also for the pre-
diction of the concentration of theophylline. Models for the
physical properties of tablets were developed individually for
each concentration of theophylline to minimize the spectral
variation originating from the change in the tablets chemical
composition. Modeling was performed using SIMCA 13.0.3
(Umetrics, Umeå, Sweden). Given that the physical features of
tablets have been described to influence spectra not only on
the form of light scattering effects (i.e. baseline offset) but also
on peak height or peak shifts, several different pretreat-
ments were tested including Standard Normal Variate (SNV)
and Multiplicative Scatter Correction (MSC) [18,20]. First and
second derivatives were also applied calculating 15-point
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quadratic Savitzky–Golay filters. Several wavenumbers were
tested to find the optimal spectral range.The parameters used
to examine the PCA models performance were R2X and Q2.The
performance assessment of PLS models was based on the R2X,
R2Y, Q2 and Root Mean Squared Error of Prediction (RMSEP).The
normalized RMSEP (nRMSEP) was also calculated. This non-
dimensional statistical parameter facilitates the comparison
between the errors of models for the prediction of properties
with very dissimilar units. The RMSEP was normalized by the
range of the measured property according to Equation (6):
nRMSEP %( ) =
−
⎛⎝⎜ ⎞⎠⎟
RMSEP
Y Ymax min
(6)
with Ymax and Ymin as the maximum and minimum values of
the property included in the model in question, respectively.
2.9. Influence of granulation parameters on granule
properties, tablet properties and tableting process parameters
To demonstrate the effect of granulation process parameters
on granulation properties, tablet properties and dependent
tableting parameters (fill depth, compression force and vari-
ability in compression force), Multiple Linear Regression (MLR)
analysis was performed using MODDE 9.1 (Umetrics, Umeå,
Sweden).
3. Results and discussion
3.1. Prediction of tablet properties using
spectroscopic techniques
3.1.1. Physical properties
PLSmodels were built separately for each of themeasured prop-
erties and theophylline contents.Two thirds of the total number
of observations was used for the model development while one
third was used for its validation. Table 2 depicts the best pos-
siblemodels found for correlating the tablets’ physical properties
with the collected spectra. It can be observed that no accept-
able models could be obtained since the (n)RMSEP values are
too high to be considered satisfactory. Even though the models
captured almost all spectral variation, mostly it could not be
correlated to any of the assayed tablets physical properties and,
therefore, no good predictions could be obtained. As an illus-
tration, plots of the observed versus predicted values for the
4 studied properties (tensile strength, friability, porosity and
disintegration time) were constructed for the NIR models for
an API concentration of 29.25% (Fig. 1).
Earlier studies have shown a correlation between spectral
information (both Raman and NIR) and tablet hardness, po-
rosity and disintegration time. However, in these studies, tablets
were prepared with the same formulation but compressed at
different compression forces yielding tablets with different
thickness, diameter and/or weight. Differently, in the current
study tableting was performed in a way that all tablets had
these properties (thickness, diameter and weight) kept con-
stant. Given this, the differences in physical properties observed
between the tablets could only be related to the properties of
the tableted granules (size distribution, friability, amount of
fines, amount of oversized particles) and thus are dependent
on the granulation parameters as varied in the performed DoE.
These findings suggested that the PAT-tools used were not able
to capture these differences in physical properties between
tablets. Hence, in manufacturing, where the variations in a sta-
bilized process are also limited, changes in tablet characteristics
would stay unnoticed. Moreover, it suggests that in research
where tablets were compressed with different compression
forces, the correlation seen between spectral data and tablet
properties was not only due to (detectable) large differences
in the extent of bonding and density, but also to differences
in the dimensions (thickness) of the measured tablets.
3.1.2. Theophylline content and hydration level
All of the assayed techniques allowed a clear distinction
between the 3 concentrations of theophylline in the tablets and
also between the levels of theophylline anhydrate and mono-
hydrate.The best PCAmodels for the visualization of this feature
can be observed in Table 3.
Fig. 2 depicts the scores and loadings of the first 2 princi-
pal components (PC) of the PCA model obtained from the
backscattering Raman data. On the score scatter plot it is pos-
sible to observe three different clusters according to PC1. The
loadings of PC1 correspond to the difference between the pure
analyte spectra of theophylline and lactose. The positive peak
at 555 cm−1 reveals that with an increase of PC1 scores there
is a simultaneous increase of theophylline anhydrate concen-
tration. Moreover, on the loadings of PC2 a positive peak of
theophylline monohydrate can be observed at 1686.9 cm−1 and
a negative peak of theophylline anhydrate at 555 cm−1. With
the increase of PC2 scores, theophylline anhydrate content de-
creases and theophylline monohydrate increases.The PC1 and
PC2 loadings of the transmission Raman model are identical
and describe the same information as the backscattering mode.
Regarding the PCA model obtained from NIR spectral data,
clustering along PC1 is also present (Fig. 3). Three individual
clusters can be observed according to the concentration of the-
ophylline. PC1 loadings contain a negative peak around
8900 cm−1, which is characteristic of theophylline and there-
fore the scores of this component are negatively correlated with
the theophylline concentration. On the other hand, PC2 load-
ings are positive at 8936 cm−1. This peak represents the
theophylline hydration level, with higher scores as the the-
ophylline hydration level increases (Fig. 3). These conclusions
agree with the findings of Fonteyne et al. [29].
PLS models were also built for the prediction of the the-
ophylline content in the tablets. Forty eight of the 72
observations (tablets) were used from each batch to calculate
the models and the remaining observations were used for vali-
dation. From all the tested pretreatments and wavenumber
ranges the combinations providing the best model for each
spectral technique were selected. Table 3 indicated that the cap-
tured variance in the spectra and in the theophylline content
is similar for all models. The 3 spectroscopic techniques also
present identical performance in predicting the content of the-
ophylline with an error of prediction around 1%.A visualization
of this predicting performance is given in Fig. 4, with plots de-
picting the relationship between the observed versus the
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Table 2 – PLS models for the prediction of the tablet properties. The range is defined as the minimum and maximum values of the corresponding property measured
in the individual tablets.
Physical
property
Theophylline
concentration
(%/tablet)
Spectroscopic
technique
Range Preprocessing Wavenumber # PC R2X (%) R2Y
(%)
Q2
(%)
RMSEP nRMSEP
(%)
TS 19.50 BRaman 0.2 to 2.2 MPa – 150–1890 2 99.0 17.0 15.8 0.351 MPa 0.181
TRaman – 150–1890 2 99.8 11.4 4.6 0.377 MPa 0.194
NIR – 8700–9500 5 99.8 40.0 24.7 0.372 MPa 0.192
29.25 BRaman 0.5 to 2.8 MPa – 150–1890 1 91.4 7.1 6.1 0.508 MPa 0.217
TRaman – 150–1890 2 98.8 27.7 26.8 0.414 MPa 0.177
NIR – 8700–9500 2 99.8 5.9 0.3 0.487 MPa 0.208
39.00 BRaman 0.6 to 3.0 MPa – 150–1890 7 99.8 52.9 42.0 0.357 MPa 0.146
TRaman – 150–1890 4 99.7 21.8 18.5 0.378 MPa 0.154
NIR – 8700–9500 2 99.8 2.7 1.3 0.516 MPa 0.211
Friab 19.50 BRaman 0.2 to 10.9% SNV 150–1890 13 99.2 96.0 93.7 0.868% 0.081
TRaman SNV 150–1890 5 96.7 63.4 62.4 2.247% 0.210
NIR – 8700–9500 6 100 49.8 47.7 2.401% 0.224
29.25 BRaman 0.1 to 2.4% SNV 150–1890 11 99.4 90.1 68.6 0.269% 0.117
TRaman SNV 150–1890 10 99.2 98.0 93.1 0.293% 0.128
NIR – 8700–9500 6 100 55.1 52.9 0.508% 0.222
39.00 BRaman 0.1 to 0.3% SNV 150–1890 13 99.6 94.8 91.7 0.022% 0.118
TRaman SNV 150–1890 6 98.9 78.4 77.8 0.027% 0.145
NIR – 8700–9500 5 100 48.4 47.5 0.040% 0.214
ε 19.50 BRaman 19.9 to 33.8% SNV 150–1890 5 97.5 74.8 66.2 1.891% 0.136
TRaman – 150–1890 2 99.9 50.9 45.2 1.392% 0.100
NIR – 8700–9500 1 88.4 1.7 0.9 4.072% 0.293
29.25 BRaman 18.8 to 31.5% SNV 150–1890 10 99.3 91.9 78.3 1.910% 0.150
TRaman – 150–1890 4 99.5 39.7 28.2 2.890% 0.228
NIR – 8700–9500 4 100 28.7 19.3 3.152% 0.248
39.00 BRaman 19.1 to 100% SNV 150–1890 1 55.9 5.4 5.0 6.047% 0.075
TRaman – 150–1890 1 92.0 0.6 0.7 5.459% 0.067
NIR – 8700–9500 1 98.5 4.4 3.6 5.750% 0.071
Disint 19.50 BRaman 73 to 611 s 1st der. 150–1890 5 96.5 84.2 74.5 69.795 sec 0.130
TRaman 1st der. 150–1890 7 99.6 99.5 90.7 57.152 sec 0.106
NIR – 7500–11520 2 99.2 53.3 42.2 99.805 sec 0.186
29.25 BRaman 228 to 717 s 1st der. 150–1890 2 83.2 23.9 17.3 94.671 sec 0.193
TRaman 1st der. 150–1890 3 92.6 36.8 9.3 86.974 sec 0.177
NIR – 7500–11520 2 96.3 20.8 9.2 108.875 sec 0.222
39.00 BRaman 547 to 1590 s 1st der. 150–1890 6 98.0 93.4 83.9 124.085 sec 0.120
TRaman 1st der. 150–1890 6 98.7 94.5 84.4 134.317 sec 0.130
NIR – 7500–11520 2 98.5 67.9 64.3 152.224 sec 0.148
TS, tensile strength (MPa); Friab, friability (%); ε, porosity (%); Disint, disintegration time (sec); BRaman, backscattering Raman; TRaman, transmission Raman; NIR, transmission near-infrared; SNV,
standard normal variate; 1st der, 1st derivative; # PC, number of principal components; R2X (%), spectral variance captured by the model; R2Y (%), variance in the measured property captured by
the model; Q2 (%), total variation predicted by the model; RMSEP, root mean square error of prediction; nRMSEP (%), normalized root mean squared error of prediction.
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predicted theophylline concentrations for all the spectro-
scopic techniques.
3.2. Influence of granulation process parameters on
granule properties
Based on the data of the particle size distribution (PSD), a sig-
nificant relationship between amount of fines, amount of
oversized agglomerates and all four process variables (API %,
LFR, BT, SC) was detected (Fig. 5A and B; Table 1). Due to the
hydrophobic character of theophylline anhydrate, the forma-
tion of liquid bridges was hampered, resulting in smaller
particles and hence a larger amount of fines. On the con-
trary, increasing the liquid feed rate, barrel temperature and
the number of kneading elements yielded less fines (4.9–
43.3% < 300 μm) and more oversized agglomerates (4.4–
43.0% > 2000 μm). Due to a larger amount of available liquid,
an increased dissolution rate and a more intensive mixing of
powder and granulation liquid, more liquid bridges could be
formed between the powders. These results are in accor-
dance with those obtained by other authors [1,22,30–33].
The friability of the granules (4.3–25.9%) was clearly af-
fected by the API %, LFR and SC (Fig. 5C; Table 1). A lower
theophylline concentration, higher liquid concentration and
more kneading elements resulted in less friable granules.These
results could also be linked with the formation of liquid bridges,
which are a requisite for strong granules, resisting mechani-
cal stress [22,25,30,32,33].
The granule bulk densities ranged from 0.369 to 0.487 g/
ml and the tapped densities from 0.432 to 0.549 g/ml (Table 1).
The number of kneading elements was the only process pa-
rameter significantly affecting these responses. Increasing the
number of kneading elements yielded higher bulk and tapped
densities, as more irregular-shaped coarse granules were
formed, leading to a better packing [22]. Since the bulk and
tapped densities were equally affected by the same process pa-
rameter, no significant effect of the process variables on the
flow properties, described by the CI, could be detected. Overall,
CIs only differed slightly from each other (7.3–14.6%) (Table 1)
and did not exceed 15%, indicating a good flowability of the
granules [34]. These conclusions were in agreement with the
results obtained by Vercruysse et al. [22] and Djuric and
Kleinebudde [33].
3.3. Influence of granulation process parameters on tablet
properties and tableting process parameters
The API % was the major factor of influence for all investi-
gated responses.An overview of the results of the tablet analysis
is given in Table 1.The responses could be linked not only with
the granulation process parameters, but also with the granule
characteristics.
For the results of tablet tensile strength, a clear influence
of the theophylline concentration and, to a lesser extent,
the liquid feed rate could be observed. A higher theophylline
concentration and, in accordance with Keleb et al. [35] and
Tan et al. [36], a lower water concentration yielded stronger
tablets. The hydrophobic character of theophylline anhydrate
and a low liquid feed rate during granulation hampered the
formation of liquid bridges, resulting in more and smaller
particles. As more fines were present, the (extragranular) spe-
cific surface area became larger [37–40]. Hence more interaction
forces were likely to occur, contributing to higher tablet tensile
strengths.
To explain the friability results, the same reasoning as for
tensile strength applies.With more fines, the specific surface
area increased and allowedmore interaction between the gran-
ules, hence forming tablets with a higher resistance toward
abrasion.This conclusion can be further supported by the ob-
servation that 9 out of 12 batches from the lowest API
concentration failed the friability test. In these cases cracked,
cleaved or broken tablets were detected after friability testing.
For the tablets produced with the intermediate API concen-
tration, this was only 4 out of 14. In contrast, none of the batches
containing the highest amount of theophylline failed, with fri-
ability values ranging from 0.1% to 0.3%.
Fig. 1 – Relationship between observed and predicted values for the NIR models for a theophylline concentration of 29.25%
of (A) tensile strength (TS), (B) friability (Fria), (C) porosity (ε) and (D) disintegration time (Disint).
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A significant positive influence of API %, LFR and SC on dis-
integration time was detected. The influence of theophylline
concentration could be explained by its hydrophobicity, which
hinders the percolation of liquid inside the granules.The effect
of the water concentration and the amount of kneading ele-
ments could be related to the density of the granules. Higher
liquid concentration stimulated the formation of liquid bridges
in the granules and kneading elements improved the distri-
bution of granulation liquid, resulting in granules with a higher
density [22,25,30,32,33]. The denser tablet structure ham-
pered the percolation of liquids inside the granules, resulting
in tablets with a longer disintegration time (108–1576 s). Re-
garding tablet porosity (20.7–31.5%), API %, LFR and BT were
identified as significant process variables. A low level of the-
ophylline and a high level of liquid feed rate and barrel
temperate resulted in tablets possessing a high porosity.These
observations were also correlated with PSD, as the same set
of process parameters yielded less fines.With less fines present,
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Fig. 2 – (A) Score scatter plot of the first ([t1]) and second
([t2]) principal components of the PCA model on
backscattering Raman. Data are colored according to the
concentration of theophylline: Red, 19.5%; Blue, 29.25%;
Green, 39%; and (B) PC1 loadings (black) and PC2 loadings
(blue).
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the intergranular pores during tableting are less likely to be
filled, resulting in a lower overall porosity of the produced
tablets. For the variation in tablet weight, illustrated by the varia-
tion coefficient (VC), the same argumentation can be followed
with the API % as the significant process variable. Since die
filling is a volumetric (and not gravimetric) process, the inter-
granular space plays an important role.When the theophylline
concentration is high, more and smaller particles are present,
which are likely to fill this space, hence increasing the vari-
ability. However, although significant, the VC for all batches is
rather small (<2.5%) and far beneath the typically tolerated 4%
limit applied for high speed tableting. These results are all in
strong accordance with previously published work on con-
tinuous granulation [22], which acknowledges the robustness
of this process.
The data of the tableting process parameters (Table 1) iden-
tified a correlation between the dependent process parameters
(fill depth (FD) (mm),main compression force (MCF) (kN), varia-
tion coefficient of main compression force (VC MCF) (%)) and
the granule process parameters and resulting granule prop-
erties. A significant negative effect of the amount of kneading
elements (SC) on fill depth can be detected. More kneading el-
ements had a significant positive effect on bulk and tapped
density: at a higher density of the packed granules, a smaller
volume (i.e. a lower fill depth) is required to obtain the same
weight (300 mg). None of the process parameters had a sig-
nificant influence on MCF, which is in accordance with the
results of CI. Furthermore, since differences in MCF between
batches were limited (4.98–6.63 kN), these results illustrate again
that all tablets were compressed at the same compression force.
It should be mentioned that the absolute value of MCF is
rather low, compared to commonly used compression forces
(8–16 kN). By keeping this value low, it was possible to obtain
tablets with different characteristics brought about by the dif-
ferent granule process parameter settings.At high compression
forces, this information is likely lost.A significant positive effect
of the API % onVC MCF was observed.These observations were
also linked to PSD and tablet weight variability. Although cor-
related, the VC in tablet weight is much smaller than the VC
in MCF, due to the exponential relation between these two
tableting parameters.
4. Conclusions
The main goal of this study, which is to predict tablet physi-
cal properties from backscattering Raman, transmission Raman
and transmission NIR spectroscopic data, was not possible to
achieve. The PAT-tools used were not able to capture the dif-
ferences in physical properties between tablets. This suggests
Fig. 3 – (A) Score scatter plot of the first ([t1]) and second
([t2]) principal components of the PCA model on
transmission NIR. Data are colored according to the
concentration of theophylline: Red, 19.5%; Blue, 29.25%;
Green, 39%; and (B) PC1 loadings (black) and PC2 loadings
(blue).
Fig. 4 – Relationship between the observed and predicted theophylline concentration (API content) for (A) backscattering
Raman, (B) transmission Raman and (C) NIR.
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that in previous research in which tablets were compressed
with different compression forces, the correlation between spec-
tral data and tablet properties was not only linked to differences
in bonding and density, but also to differences in tablet di-
mension (thickness).
In accordance with previous research it was possible to
predict the theophylline content by means of a PLS ap-
proach.All spectroscopic methods revealed a similar prediction
performance with an RMSEP around 1%. PCA models allowed
a distinction between the three different levels of theophyl-
line and a determination of the API’s hydration level.
Furthermore, the effect of several granulation process vari-
ables on granule quality, tablet quality and measured tableting
parameters was evaluated by means of a DoE. For the granule
properties, theophylline concentration and moisture content
were identified as the most important parameters. The same
effect of theophylline concentration was observed for the tablet
properties. The dependent tableting parameters were mainly
influenced by the API concentration (VC MCF) and the screw
configuration (FD).
Even though it was not possible to predict tablet physical
properties with the applied spectroscopic techniques, these PAT-
tools have a significant added value when applied for the
monitoring of a continuous process since API concentration
is an important parameter influencing both granule and tablet
properties and it is an important quality attribute for the end
product. Based on the good models for this process param-
eter, implementation of NIR and/or Raman probes in a tablet
production line will contribute to the monitoring, adaption and
understanding of the process as well as to quality assurance
of the end product.
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